Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel therapies for narcolepsy.

Stephen Brooks1, Jed Black

  • 1Stanford Sleep Disorders Clinic, 401 Quarry Road, Suite 3301, Stanford CA 94305, USA. stephen.brooks@Stanford.edu

Expert Opinion on Investigational Drugs
|November 30, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing Bragg-peak FLASH proton irradiator using permanent magnet synchrotron.

Journal of radiosurgery and SBRT·2026
Same author

Prevalence of diagnosed idiopathic hypersomnia among adults in the United States 2019-2023: analysis of healthcare claims.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

Type I Interferon Signature is Associated With Lung Disease, Drug-Associated Immune Reactions, and Genetic Variation in Interferon-Linked Pathways in Still Disease.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Effects of low-sodium oxybate on diary-based sleep time in a clinical study in adults with idiopathic hypersomnia.

Sleep medicine·2025
Same author

Epigenetic dysregulation in aged muscle stem cells drives mesenchymal progenitor expansion via IL-6 and Spp1 signaling.

Nature aging·2025
Same author

The Clinical and Economic Burden of Idiopathic Hypersomnia and Narcolepsy: A United States Claims-Based Analysis.

Nature and science of sleep·2025

Narcolepsy, a neurological disorder causing excessive sleepiness, may soon see new treatments targeting the hypocretin system. Research is exploring novel therapeutic approaches beyond current, often ineffective, medications.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Neuroscience

Background:

  • Narcolepsy is a disabling neurological disorder characterized by excessive daytime sleepiness and cataplexy.
  • The exact cause of narcolepsy remains unknown, but recent discoveries have illuminated the role of the hypocretin system in its pathophysiology.
  • Current treatments for narcolepsy offer symptomatic relief but are frequently inadequate and poorly tolerated.

Purpose of the Study:

  • To explore novel and emerging therapeutic strategies for narcolepsy.
  • To address the unmet need for more effective and better-tolerated narcolepsy treatments.
  • To highlight the potential broader applications of new narcolepsy treatments in other conditions.

Main Methods:

  • Review of recent scientific literature on narcolepsy pathophysiology and treatment.

Related Experiment Videos

  • Analysis of emerging therapeutic targets, particularly those related to the hypocretin system.
  • Discussion of potential new pharmacological agents and therapeutic modalities.

    • Main Results:

    • Significant advancements in understanding narcolepsy pathophysiology, especially concerning the hypocretin system.
    • Identification of several promising new therapeutic avenues for narcolepsy management.
    • Recognition that new treatments may have utility beyond narcolepsy.

    Conclusions:

    • The understanding of narcolepsy has advanced, revealing the hypocretin system as a key factor.
    • New therapeutic approaches are under investigation, offering hope for improved narcolepsy management.
    • These novel treatments may hold potential for broader clinical applications.